A dual-pathway treatment
Tirzepatide acts on both GIP and GLP-1 pathways involved in appetite and food intake.
Weekly GIP/GLP-1 weight-management care
Tirzepatide Weight Loss
Personalized tirzepatide treatment with medical screening, dose guidance, regular follow-up, and support throughout your weight-management plan.
Starting at $349/month
Maryland statewide Private telehealth Provider-guided care
Understand the dual pathway
Tirzepatide care begins with individual eligibility
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It acts on hormone pathways involved in appetite and food intake and may be considered for chronic weight management in eligible adults alongside healthy eating and physical activity.
Reniel Health evaluates Maryland adults through private telehealth care. Your provider reviews whether tirzepatide is appropriate, explains the exact medication and fulfillment pathway, and creates a dosing and follow-up plan based on clinical need.
Care starts with clinical fit
Your provider reviews your health history, current medications, goals, and potential risks before recommending care. Booking a visit does not guarantee a prescription.
Provider evaluation
A dual-pathway medicine still requires a personal plan
Treatment selection is based on the whole clinical picture, not on a medication’s popularity. Your provider considers your current health, other prescriptions, previous treatment, preferences, and potential contraindications.
- Medical, family, and medication history review
- Discussion of benefits, risks, and alternatives
- Provider-selected dosing and pharmacy pathway
- A clear plan for follow-up and questions
Continuity of care
Treatment decisions continue after the first visit
Follow-up helps your provider understand how you are responding and whether the current plan remains appropriate. Dose changes, continuation, or a different approach should be based on clinical review.
Nutrition, movement, sleep, and sustainable routines remain important parts of weight management while using tirzepatide or any other prescription pathway.
Simple, private, supported01 02 03
How telehealth care works
Book and share
Choose your visit and complete a secure health intake from home.
Meet your provider
Meet by telehealth to review your history, symptoms, goals, and options.
Continue with support
If treatment is appropriate, receive a personalized plan and follow-up guidance.
Questions, answered
Before your visit
Clear expectations make it easier to choose your next step with confidence.
How is tirzepatide different from semaglutide?
Tirzepatide acts on two hormone pathways, GIP and GLP-1, while semaglutide acts on the GLP-1 pathway. Both require individual medical evaluation and provider guidance.
Who may be eligible for tirzepatide?
Eligibility depends on your health history, current medications, weight-related needs, contraindications, and provider assessment. Booking does not guarantee treatment.
Who determines my tirzepatide dose?
Your provider determines the starting dose and whether later adjustments are appropriate. Do not change a dose without clinical guidance.
How is treatment safety monitored?
Your provider discusses possible risks, medication interactions, and warning signs relevant to your history before treatment. Follow-up is used to review tolerability and response.
Care, simplified.
Ready for a plan built around you?
Begin with a private telehealth visit from anywhere in Maryland.